By: IPP Bureau
Last updated : June 17, 2022 6:22 am
Wedgewood Pharmacy operates compounding pharmacies that offers sterile and non-sterile compounded medications for animal patients in 50 states.
Osceola Capital (Osceola), a lower middle-market private-equity firm, announced The eighth addition to the Revelation Pharma Corporation (Revelation) platform by purchasing Wedgewood Pharmacy's human-health book of business.
Wedgewood Pharmacy operates compounding pharmacies that offers sterile and non-sterile compounded medications for animal patients in 50 states. Terms of the transaction were not disclosed.
The acquisition of Wedgewood Pharmacy's book of business represents Revelation's continued desire to acquire and grow a national partnership of 503A and 503B compounding pharmacies and Wedgewood Pharmacy's strategy to focus on compounding exclusively for animal health in its compounding pharmacies.
Compounded medications are created and prepared by specially trained pharmacists and pharmacy technicians in state-regulated pharmacies when mass-manufactured drugs are not, according to a prescriber, available or are not appropriate for a patient.
The corporate team for Revelation is led by Richard Case, a healthcare M&A industry veteran. Serving as Chairman of the Board, Jake Beckel, a pharmacist, has deep experience in the compounding space. He most recently served as founder and CEO of AnazaoHealth Corporation, a leading compounding pharmacy that successfully completed 13 acquisitions and ultimately was acquired by Fagron, the world's largest publicly traded compounding company.